Italy moves to cut diagnosis-related medical errors:
This article was originally published in Clinica
Executive Summary
The Italian health ministry is in the process of establishing a healthcare risk observatory, in a bid to cut the high incidence of medical errors attributed to faulty diagnoses, poor care or badly organised services. According to the national agency for regional healthcare services (ASSR), the initiative will also see the creation of a national database of medical errors. These plans follow an initial report by a commission set up to assess the risk of errors in each specialism and clinical setting. It has found that orthopaedics and trauma account for most errors (16%), followed by oncology (13%), obstetrics and gynaecology (10.8%), and general surgery (10.6%). Estimates of the number of related deaths, however, vary widely: between 14,000 (national anaesthetists association) and 50,000 (unofficial healthcare risk reports), according to the ANSA news agency. Medical errors are estimated to cost Italy around Euros10bn ($12.3bn) annually.
You may also be interested in...
Common Regulatory Starting Point Means EU-UK Are On Track For Medtech MRA, Say German Firms
With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.
COVID-19 Vaccines Donated To Philippines Require Emergency Use Authorization
Days after a senior Chinese government official offered free COVID-19 vaccines to the Philippines government, the country’s medicines regulator said the donated jabs would need an emergency approval before they can be used on the public.
Purespring Therapeutics: Pioneering Gene Therapy For Kidney Disorders
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: